Teva Pharmaceutical's stock is up 69% since December, driven by legal resolution, blockbuster drugs, debt reduction, and new product launches.Recent developments include the launch of biosimilars and ...
Source LinkTeva Pharmaceutical's stock is up 69% since December, driven by legal resolution, blockbuster drugs, debt reduction, and new product launches.Recent developments include the launch of biosimilars and ...
Source Link
Comments